---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-011191"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-03-28T23:59:59+00:00"
generated_at: "2026-05-24T03:24:20.168960+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Series B Preferred holders convert ~609K shares of common stock, aggregate stated value $913K

## Summary
- On March 25, 2025: 116 shares (stated value $127,600) converted to 85,067 common shares.
- Same day: 350 shares ($385,000) to 256,667 common; 146 shares ($160,600) to 107,067 common.
- On March 26, 2025: 218 shares ($239,800) converted to 159,867 common shares.
- All conversions at $1.50 per share; no commissions paid, exempt under Section 3(a)(9).

## SEC filing metadata
- accession: 0001493152-25-011191
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-03-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225011191/0001493152-25-011191-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225011191/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-011191
- JSON: https://secwatch.observer/filing/0001493152-25-011191.json
- Plain text: https://secwatch.observer/filing/0001493152-25-011191.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.